NEW HORIZONS FOR NUTRITIONAL THERAPYIn our established business areas – Consumer Care and Medical Nutrition – we already have a comprehensive range of products that help correct or improve nutritional status that are important – and in some cases – clinically proven to be a vital part of disease recovery or health management.
Now, new opportunities are emerging based upon scientific advances (omics) being made about both the nature of disease and the potential of nutritionally related innovations to directly impact them in a clinically proven way, with a known mode of action. This creates the potential to bring forward innovations with a more direct and clinically proven therapeutic impact. That’s why we set up an additional business area: Novel Therapeutic Nutrition.
We are committed to be the company ‘where nutrition becomes therapy’ across all area of our business, Consumer Care, Medical Nutrition and Novel Therapeutic Nutrition.
Our Medical Nutrition portfolio includes products and services recommended by healthcare professionals (HCPs) for patients with specific dietary needs related to illnesses, disease states or special challenges of different life stages. Our products are most relevant to the institutional sector – including hospitals, care homes and homecare – and are recommended by HCPs with reimbursement by insurers or public health services. The current portfolio is focused upon Inborn Errors of Metabolism, Paediatric Care & Allergy, Acute Care & Devices and Oncology Care. Our Medical Nutrition products are recommended by healthcare professional and used in hospitals, nursing homes, and in home care.
In Novel Therapeutic Nutrition, we are investing in companies with a range of nutrition-based technology platforms aiming to bring forward clinically proven innovations, initially in the areas of brain and gastrointestinal health. In brain health and Alzheimer’s disease for example, we are supporting further clinical trials of a product, which helps the brain to process glucose needed for effective brain function.
And in gastrointestinal health, one of our initiatives is to invest in the development of microbiome therapeutics. These have the potential to address the underlying causes of many types of diseases by restoring the gut microbiota to a healthy state. This healthy state can be disrupted by different health conditions such as trauma or even drugs.
Nestlé Health Science is a new, innovative and fundamentally different type of company: we are a health science company focused upon advancing nutritional therapy to change the course of health – for people, patients and our partners in healthcare.
It’s a compelling opportunity.
Do you want to learn more about Nestlé Health Science? Please visit: https://www.nestlehealthscience.com/newsroom/videos